LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Development and Challenges of Synthetic Retinoid Formulations in Cancer.

Photo from wikipedia

Retinoids represent a class of chemical compounds derived from, or structurally and functionally related to vitamin A. Retinoids play crucial roles in regulating a range of crucial biological processes spanning… Click to show full abstract

Retinoids represent a class of chemical compounds derived from, or structurally and functionally related to vitamin A. Retinoids play crucial roles in regulating a range of crucial biological processes spanning embryonic development to adult life. These include regulation of cell proliferation, differentiation, and cell death. Due to their promising characteristics, retinoids emerged as potent anti-cancer agents, and their effects were validated in in vitro and in vivo pre-clinical models of several solid and hematological malignancies. However, their clinical translation remained limited due to their poor water solubility, photosensitivity, short half-life, and toxicity. To overcome these limitations, the development of retinoid delivery formulations was extensively studied. In this review, we will provide a comprehensive summary of some preclinical and commercial synthetic retinoids in cancer and discuss their different delivery systems.

Keywords: development; synthetic retinoid; development challenges; challenges synthetic; cancer

Journal Title: Current drug delivery
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.